Explore our brands

Our brands bring together the industry's most influential leaders and scientific experts, inspiring thought-provoking and insightful content that offers a unique perspective on R&D trends and challenges.
Contact
Proteins & Antibodies Logo

PART OF NEXTGEN BIOMED 2027

18 - 19 March 2027 | InterContinental London - The O2, London, UK

Programme Summary

Delve into the latest advances in protein & antibody discovery, engineering and development, with leading experts exploring novel discovery platforms, AI/ML-guided design, developability and next-generation biologic formats. Discover emerging strategies in analytical characterisation, stability and quality control, alongside innovations in protein expression, purification and production to accelerate the development of more effective, developable biologics.

DAY TWO

Proteins, Antibodies, ADCs Keynote Address

CHARLOTTE DEANE MBE, Professor, University of Oxford

Professor Charlotte Deane MBE is a bioinformatician at the University of Oxford, known for pioneering work in protein and antibody modelling and for developing widely used research tools. She led UKRI’s COVID-19 response, earning an MBE in 2022, and has held senior roles including Head of Oxford’s Statistics Department. In 2023, she became Executive Chair of EPSRC, highlighting her impact on science, leadership, and policy.

2027 Highlights

Dive into breakthrough technologies shaping biologics discovery & development -from protein and antibody display to AI-driven engineering, stability-focused analytics, multi-specifics, novel formats, and end-to-end insights in upstream & downstreamprocessing.

NextGen Biomed - What to Expect Presenting 2
NextGen Biomed - What to Expect Networking 4
1000

leading pharma, biotech, regulatory & academic delegates

700
pre-arranged 1-2-1 meetings, facilitating business growth
50
hours of presentations, discussions & interactive content
12
hours of networking breaks, including fireside chats & refreshments
NGB + LSX Combined Logo-1

Unlock the Latest News and Insights

Sign-up for our regular LifeScienceXchange newsletter to keep up to date with all things NextGen Biomed, direct to your inbox.

NGB Newsletter Icon-1

Proteins, & Antibodies - Agenda at a Glance

DAY ONE TRACKS

Track 1: Antibody Discovery & Engineering, Display Technologies
Track 2: Emerging Analytical Techniques, Developability & Quality Control Systems
Track 3: Upstream Development: Novel Strategies For Cell Line Development & Expression Optimisation
Track 4: NextGen Multi-Specifics, Cell Engagers & Other New Modalities
Track 5: ADC Design, Validation & Optimisation to Enhance Their Therapeutic Potential

DAY TWO TRACKS

Track 1: AI/ML-Guided Protein &  Antibody  Engineering
Track 2: Analytical Development: Stability & In-Depth Characterisation Methods For  Proteins &  Antibodies
Track 3: Downstream Development:
Protein Purification & Recombinant Protein Production
Track 4: ADC Pre-Clinical & Translational Development

NGB 2026 Laptop Agenda

Featured Speakers for Proteins & Antibodies 2027

Alexia Hapeshi
Associate Research Director,
NanoSyrinx
Andrew Creese
Scientific Director, Analytical Development at Immunocore,
Immunocore
Aneesh Karatt Vellatt
Chief Scientific Officer,
Maxion Therapeutics
Bryce Nelson
Head of Antibody Discovery,
Orion Pharma
Christian Graf
Fellow Scientific Office Biologics,
Novartis
Christine Rothe
CDO,
iOmx Therapeutics
Colette Johnston
VP - Head of Product Platform Research,
Enara Bio
Erik Anders Vernet
Sr Dir,
Novo Nordisk A/S
Giuliana Vozza
Senior Scientist,
AstraZeneca
Héloïse Quillay
Principal Scientist, Lab Head,
Sanofi
Hilde Stals
Director CMC,
Argenx BVBA
Matthew Burrell
Associate Director,
AstraZeneca
Show More Speakers
Hide Speakers
Preeti Bakrania
Head of Partnerships, Platforms,
LifeArc
Stefan Dübel
Director,
Technische Universitat Braunschweig
Thomas Jostock
Associate Director,
Novartis Pharma
Thomas Powell
Senior Scientist,
Immunocore
Winston Haynes
Vice President, Computational Sciences and Engineering,
LabGenius

Interested in Sponsoring NextGen Biomed?

Become a driving force in accelerating the next generation of biologics and immunotherapy medicines to patients. NextGen Biomed offers a unique platform to enhance your brand visibility and connect with thousands of pharma, biotech, and R&D experts. Our branded event opportunities, immersive experiences, and content services enable you to engage, educate, and collaborate with the community shaping the future of biomedicine today.

Register Now

Be part of the new wave of Biomed R&D innovation

Partner with us

Become a driving force in accelerating the next generation of biologics and immunotherapy medicines to patients